Abstract Dendritic cells (DC) are the most ecient antigen presenting cells. The clinical use of DC as vectors for antitumor and anti-infectious disease immunotherapy has been limited by their low level and accessibility in normal tissue. Substantial numbers of DC can be generated from peripheral blood cultured in the presence of interleukin-4 (IL-4) and granulocyte/ macrophage-colony-stimulating factor (GM-CSF). We showed in this study that substantial numbers of DC can be obtained from the peripheral blood of patients with (pre)neoplastic lesions of the uterine cervix. The procedure required relatively small blood samples (10 ml) and the presence of 100 U/ml IL-4 and 800 U/ml GM-CSF in the culture medium. There was no signi®cant dierence in the morphology, yield, phenotype and function of generated DC between patients with cervical (pre)-neoplastic lesions and healthy individuals. When the hematopoietic factor Flt3 ligand (Flt3L, 40 ng/ml) was added, there was an average increase in the DC population of 26% compared to cultures with GM-CSF and IL-4 alone. Approximately 1.2´10 6 cells with the characteristics of dendritic cells could be obtained when Flt3L was included in the medium. A and CD14 A ). In addition, Flt3L generated functional DC capable of stimulating the proliferation of alloreactive T cells. These results suggest that Flt3L, in association with GM-CSF and IL-4, provides an advantageous tool for the large-scale generation of DC and that an immunotherapy based on the use of DC generated in vitro is possible in patients with (pre)neoplastic lesions of the uterine cervix.
Introduction
Accumulation of immunological, molecular and clinical evidence has implicated human papillomavirus (HPV) infection as an essential factor in the development of invasive cervical cancer and its precursor lesions [22, 31] . Squamous intraepithelial lesions (SIL) refer to a group of premalignant changes in the epithelium of the uterine cervix that precede the onset of invasive cancer.
The general or local immune state might be expected to have a key role in host defense against HPV infection and the possible development of cervical carcinoma. The nature of an eective immune response to HPV infections is not well understood, although cell-mediated immunity is thought to be more important than humoral immunity [50] . Several studies have described a localized immune dysfunction accompanying cervical HPV infections and associated cervical lesions. Speci®cally, alterations in the number and cytokine pro®les of T helper lymphocytes have been reported [2, 5, 49] . On the other hand, alterations in the density, distribution and morphology of Langerhans cells have been shown in both papillomavirus-infected and (pre)neoplastic cervical epithelium [30] . Several explanations have been proposed to explain the changes of Langerhans cells locally in SIL [16, 21, 29] . These lesions develop in the transformation zone of the cervix, where there is a low density of Langerhans cells, even in the absence of HPV infection [1, 2, 8] . Other authors have suggested that these changes might be due to the cytopathic eect of the virus [38] . Alterations of membrane molecules of infected keratinocytes (loss of E-cadherin) might contribute to the reduction of Langerhans cells or to their functional inability [48] . HPV infection of the keratinocytes has been shown to alter the production of immunoregulatory cytokines that are likely to have a stimulatory eect on Langerhans cells (tumor necrosis factor a, TNFa; granulocyte/macrophage-colony-stimulating factor, GM-CSF) [27] . Another possibility is that the immunosuppressive cytokine interleukin-10 (IL-10), which is expressed in SIL, plays a role in the depletion or inhibition of Langerhans cells [13] . Langerhans cells belong to the family of dendritic cells (DC), which are the most important professional antigen-presenting cells (APC) in the immune system. Because host professional APC are among the most important elements in the induction of speci®c antitumor immune responses, quantitative or qualitative alterations of these cells could be partly responsible for the immunotolerance of HPV-associated cervical (pre)neoplastic lesions.
Although DC are present in small numbers, they act as sentinels of the immune system because they are widely distributed in the body [36] . DC are critically involved in the initiation of primary immune responses, in vivo graft rejection and development of T-celldependent antibodies [4, 46] . Unlike other APC (monocytes, macrophages), DC may be crucial because of their potential to recruit resting T cells to initiate an immune response [20] . They are very specialised in this function, as re¯ected by their constitutive expression of high levels of major histocompatibility complex class II molecules, adhesion molecules and expression of CD80 (B7.1) and CD86 (B7.2) on their surface [6, 10] .
By virtue of their developed antigen-presenting capacity, DC are ideal targets to manipulate the immune system. The use of DC as cellular vectors for antitumor and anti-infectious disease vaccines or as inducers of transplantation tolerance is a promising immunotherapy strategy [26, 51] . However, the clinical feasibility of using DC as immunotherapy vectors has been hampered by their scattered location and very low frequency [7] .
In recent years, several laboratories have devised dierent methods to amplify the number of DC by culturing DC precursors from dierent origins. DC can be generated from CD34 + hematopoietic progenitor cells isolated from bone marrow of healthy donors [34, 43] or from peripheral blood of cancer patients undergoing autologous stem-cell transplantation [3] . Cord blood has been reported to be another source of CD34 + progenitor cells [40] . Both the proliferation and maturation of DC are enhanced by the cooperation of GM-CSF and TNFa [35] . However, the applicability of these approaches has been somewhat limited by the low levels of CD34 + cells and by the relatively tedious techniques required. Recently, another source of DC progenitors (monocytic precursors) has been discovered in adult blood [37] . Indeed, the dierentiation of DC involves at least two pathways. DC can be generated from an early bone marrow precursor (CD34 + ) or from cells of the monocytic lineage (CD14 + ) [32] . The monocytic precursors are induced to proliferate and to dierentiate in the presence of GM-CSF and IL-4. IL-4 acts by suppressing macrophage development and by favoring differentiation of DC from monocytic precursors [19] .
Whatever the approach used to obtain DC (from CD34 + or monocytic precursors), their yield depends mainly on the initial number of precursor cells. This suggests that the ex vivo generation of large numbers of DC may bene®t from the addition of hematopoietic growth factors. Flt3L is a recently identi®ed hematopoietic growth factor [24] . It has been shown to stimulate the proliferation of hematopoietic stem and progenitor cells [23, 28] and to induce the proliferation and dierentiation of monocytes [11] . The purposes of this study were to examine the eect of Flt3L on the maturation of DC from peripheral blood and to determine whether the generation of DC diers between healthy donors and patients with cervical SIL. We have shown that Flt3L is very ecient in increasing the generation of DC from human peripheral blood mononuclear cells (PBMC), without altering their phenotype or allostimulatory capacities. No dierence was observed between patients with SIL and healthy women. These results might help to improve our understanding of the role of DC in HPV infections and malignant diseases and help us to evaluate the potential use of DC in HPV-associated cancer immunotherapy.
Materials and methods

Culture medium
The medium used in this study was RPMI-1640 supplemented with 10% heat-inactivated fetal calf serum (FCS), 1% non-essential amino acids, 1% sodium pyruvate, 50 lM 2-mercaptoethanol, 30 U/ml penicillin, and 30 lgaml streptomycin (all obtained from Gibco BRL, Life Technologies). This medium is reported to as complete medium.
Recombinant human cytokines and growth factors GM-CSF (11.1´10 6 U/mg) was kindly provided by Dr. A. Gossens (Schering-Plough, Brussels). IL-4 (5´10 6 U/mg) and Flt3L (1X1 Â 10 6 Uamg À 20 lgaml) were purchased from Genzyme Diagnostics (Cambridge, Mass.).
Study group
Fifteen patients with histologically con®rmed SIL of the cervix were selected for this study. Biopsies were diagnosed as low-grade SIL in ®ve patients and as high-grade SIL in ten patients. The mean age of the group was 33 years. Six age-matched healthy volunteers were used as controls.
Dendritic cell cultures
Peripheral blood was collected on EDTA from the patients before laser conisation. In some experiments, leukocyte-enriched buycoats were used as a source of mononuclear cells.
PBMC were isolated by Ficoll-Hypaque density-gradient centrifugation. After washings at low centrifugation speed to remove the maximum number of platelets, PBMC were plated in six-well dishes (Nunclon D Multidishes, Nunc, Denmark) at a density of 10´10 6 cells/well in 3 ml complete medium without FCS. After 18 h at 37°C, non-adherent cells were discarded by two gentle washes with 1.5 ml complete medium. The adherent cells were cultured with 800 U/ml GM-CSF and dierent concentrations of IL-4 (see results) in 3 ml complete medium/well. These cultures were supplemented or not with dierent concentrations of Flt3L (see results). IL-4 was added every 2 days and cultures were fed every 3 or 4 days with fresh medium containing the appropriate cytokines. Cells were harvested at dierent times points (day 7, 14 and 21) for phenotypic, morphological and functional analysis. Harvesting was performed by adding 1.5 ml EDTA 1 mM in phosphate-buered saline without calcium, for 20 min at room temperature.
Flow-cytometric cell surface marker analysis Samples containing 4±5´10 5 cells were incubated for 20 min at 4°C in Hank's buer (Life Technologies) with speci®c mAb (listed in Table 1 ). Cells were stained either directly with¯uorescein-isothiocyanate(FITC)-or phycoerythrin(PE)-conjugated monoclonal antibodies (1/5 dilution), or indirectly with streptavidin-PE (2 ll/staining, Boehringer Mannheim) or with irrelevant control isotype-matched mAb (Becton-Dickinson). After washing, cells were resuspended in Hank's buer and analyzed. Two-or threeuorescent-color staining was performed. Propidium iodide (1 lg/ ml) was used to exclude dead cells. Cells were analyzed for¯uo-rescence intensity on a FACStarPlus¯ow cytometer (Becton Dickinson). Forward light scattering, orthogonal light scattering and three¯uorescence signals were determined for each cell and at least 20 000 events were accumulated for each measurement.
Cytochemical staining
Cytospins of DC cultures were prepared by spinning (200 rpm) (0.5±1)´10 5 cells onto silanized slides and ®xed in cold acetone for 3 min. Giemsa staining was performed using standard procedures.
Mixed lymphocyte reaction assay
Stimulator populations consisted of cells grown in GM-CSF + IL-4 (100 U/ml) or GM-CSF + IL-4 + Flt3L for 7 days. After centrifugation for 10 min at 200 g, the cells were adjusted to equal concentration in RPMI-1640 medium containing 5% human pooled AB serum without exogenous cytokines and irradiated with 30 Gy. Varying numbers of stimulator cells (500±50 000 cells/well) were then added to round-bottomed 96-well plates (Nunclon) containing 1´10 5 allogeneic PBMC/well. The tests were performed in quintuplate. A proliferative response was measured after 6 days of culture by adding 1 lCi [ 3 H]thymidine to each well. Cells were harvested 18 h later by an automated sample harvester (Packard, Canberra, Tilburg, The Netherlands) and counted in a liquid scintillation counter (Top Count, Packard, Canberra). Thymidine uptake in irradiated stimulator cells was below 640 cpm and in responder cells cultures alone it was below 240 cpm.
Statistical analysis
In experiments concerning the eect of Flt3L on HPV patients compared with healthy donors, the Mann-Whitney test for paired samples was used for statistical evaluation. In other experiments, the analysis of variance test for paired samples was used.
Results
Assessment of the optimal culture conditions for the generation of DC from adherent PBMC Before working on the generation of DC from the peripheral blood of patients with SIL, we optimised the IL-4 concentration in the cultures by using buy-coat samples from normal donors as sources of PBMC. Following the 18-h adherence to plastic at 37°C, we observed an adherent fraction made up of monocytes (47 10%) and lymphocytes (41.9 22%). This adherent fraction was cultured in RPMI-1640/10% FCS supplemented with 800 U/ml GM-CSF, as recommended by previous studies [29, 33] , and various concentrations of IL-4 (0±1000 U/ml). Fluorescenceactivated cell sorting (FACS) analysis, with an antiCD1a monoclonal antibody, was performed to determine the yield of DC obtained after 7, 14 and 21 days of culture. Figure 1A shows the results expressed as the percentage increase of CD1a + cells in the presence of various doses of IL-4 compared with cultures containing GM-CSF alone. The maximum yield of CD1a + cell was observed at day 7 of culture with 100 U/ml IL-4 (P < 0.001). With these culture conditions, 63 18% of the cells showed a phenotype of dierentiated DC (CD1a + /CD14 A ). The range of increase, compared with CD1a + cells obtained at day 7 with 1000 U/ml of IL-4, was 30%±50%. After long-term cultures (14 and 21 days), the number of total nucleated cells decreased as well as the yield of DC. This observation was documented in four independent cell cultures.
We also tested the eect of graded doses of Flt3L (0±80 ng/ml) on PBMC from buy-coats of healthy donors. Flt3L, at a concentration of 40 ng/ml, in association with GM-CSF and IL-4, induced the maximal expansion of CD1a + cells in all donors examined. We showed that these conditions were responsible for a mean increase of 50% in the number of DC (P < 0.001) (Fig. 1B) .
For subsequent experiments, we therefore decided to use 40 ng/ml Flt3L, 100 U/ml IL-4 and 800 U/ml GM-CSF to generate DC.
Morphological and phenotypical analysis of CD1a + cells cultures in the presence of Flt3L
The monocytic adherent fraction of 10´10 6 mononuclear cells from peripheral blood of patients with SIL or from healthy individuals was cultured in medium containing GM-CSF (800 U/ml) and IL-4 (100 U/ml) sup- Over the next few days, these veiled DC were slowly released. There was no morphological dierence between cells cultured with GM-CSF + IL-4 alone and those cultured in medium supplemented with Flt3L (Fig. 2) . These observations were similar for cells from patients with SIL and healthy donors.
We also compared the phenotype of DC generated with and without Flt3L by FACS analysis. DC could be distinguished from contaminating lymphocytes by their size and granularity. As shown in Fig. 3A , gated cells containing DC presented signi®cantly increased forward-scatter and side-scatter values as compared with lymphocytes. Therefore, we used these parameters to gate the DC. The gated cell population was similar for cultures unsupplemented or supplemented with Flt3L. Between 20% and 75% of the cells cultured without Flt3L were in this gate compared to 30%±80% for cells generated with Flt3L. Thus, the DC dierentiation pathway (with and without Flt3L) was associated with the same changes in size and granularity, leading to cells that were considerably larger and more dense than granulocytes and monocytes. Figure 3B demonstrates that the cells generated with or without Flt3L display the typical surface phenotype of dendritic cells [32] : (1) expression of the Langerhans/dendritic cell molecule CD1a, (2) co-expression of CD4, and (3) absence of the macrophage and T cell markers CD14 and CD3. However, small numbers of CD3 + and CD20 + (not shown) cells were detected by FACS analysis in the gated cell population and were probably related to the formation of cell``rosettes'' between DC and either T cells or B cells. Other typical features included (4) increased expression of class II MHC (HLA-DR) molecules, (5) high-level expression of the adhesion molecules ICAM-1 (CD54) and CD40, and (6) expression of the co-stimulatory molecules B7.1 (CD80) and B7.2 (CD86). No dierences were observed in the level of expression of all these markers in cultures with and without Flt3L. Patients with SIL did not dier signi®cantly from control individuals.
Eects of Flt3L on the yield of DC in patients with cervical SIL and healthy donors
The eect of Flt3L on CD1a + cell generation was examined using peripheral blood from 15 patients with HPV-associated SIL and 6 healthy donors. At day 7, cells cultured in GM-CSF + IL-4, with or without Flt3L, were counted and the number of CD1a + cells was determined by FACS analysis. Addition of Flt3L to the culture medium did not result in a signi®cant increase in the total number of cells either in patients with SIL or in healthy donors (data not shown). In contrast, the addition of Flt3L induced an important and signi®cant expansion of CD1a + cells either in patients with SIL (P < 0.0001) or in control individuals (P 0.0312). The results are expressed, in Fig. 4 , as the percentage increase in CD1a + cells, compared with cells cultured in normal medium (GM-CSF + IL-4 alone), for each PBMC donor.
Interestingly, the proportion of DC obtained in cultures without Flt3L from patients with SIL was the same as that from control individuals. When Flt3L was added, this proportion increased, but to the same extent in both patients and healthy individuals (data not shown).
The eect of Flt3L on the yield of CD1a + cells varied among donors. The individual increments observed with Flt3L varied between 18% and 53% with a mean in- When Flt3L was added to the culture, (1.14 0.26)´10 6 (n 7) CD1a + cells were obtained after 7 days from blood samples having a volume as low as 10 ml. Similar results were obtained for both patients and healthy individuals.
Functionality of DC generated with and without Flt3L. Allostimulatory capacity Cell populations from cultures with and without Flt3L for one healthy donor and two patients with SIL were compared for their capacity to provide accessory signals for an ecient proliferation of responder cells in an allogeneic test.
As shown in Fig. 5 , the capacity to produce a potent mixed lymphocyte reaction was retained even at stimulator:responder ratios as low as 1000:100 000, which is consistent with a DC-mediated T cell response [47] . DC generated from precursors in the peripheral blood of patients and DC obtained from healthy donors did not dier signi®cantly in their ability to stimulate an allogeneic response.
The stimulatory capacity of the cell population generated with GM-CSF + IL-4 + Flt3L was generally higher than that of the population induced with GM-CSF + IL-4. These results support the idea that there was a higher proportion of stimulatory cells (i.e. DC cells) in the populations generated with Flt3L.
PBMC from the same donors were used as controls and were much less eective in all assays. Independently of the cytokines used to generate DC, mixed lymphocyte reactivity correlated with the percentage of CD1a + /
CD14
A cells present among stimulating cells (data not shown).
Discussion
This study was designed to assess the optimal modalities for the large-scale procurement of functional DC starting from a relative small quantity (10 ml) of peripheral blood from patients with preneoplastic lesions of the uterine cervix (SIL) and to determine whether the generation of DC diers between healthy women and patients with SIL, since tumor-derived factors have been shown to aect the ability of precursors to dierentiate into DC [12] . Moreover, previous studies have reported a depletion and qualitative alterations of Langerhans cells in SIL compared to a normal squamous mucosa during the HPV-associated cervical carcinogenesis [1, 45] . This ®nding might be due to an altered generation of DC or to a lack of maturation/migration of DC in relation to a decreased production of chemotactic factors by epithelial cells in the presence of HPV [14] . Because of the central role of DC in the generation of an eective cellular immune response, a defect in these cells might make the development of a speci®c CTL response almost impossible in neoplastic cervical epithelium infected with HPV. These observations highlight the need for methods generating a large-scale production of DC in vitro for a better understanding of their role in HPV-associated (pre)neoplastic lesions. The development of methods generating a large number of functionally active DC was prompted by studies suggesting that administration of tumor-antigen-pulsed DC to cancer patients might help to counteract disturbance of immune functions [15] . In the ®eld of HPV-associated pathology, some experiments have shown that a protective and therapeutic antitumor immunity may be generated against HPVtransformed cells in animals by using vaccination protocols with viral-peptide-pulsed autologous DC [26, 52] . In humans, this approach was shown to be eective for inducing peptide-speci®c CTL that recognise processed E6 and E7 peptides in vitro [9] . An ecient expansion of autologous DC might therefore be clinically useful. Several investigators have shown that DC may be generated in liquid suspension cultures from blood monocytic precursors by using a combination of GM-CSF and IL-4 [17, 35, 37] . However, this technique is limited by the low frequency of monocytic precursors. The hematopoietic activity of some stimulatory factors such as Flt3L [11, 23, 24] might help to improve the production of DC from PBMC. Currently, hematopoietic growth factors have been tested for their eect on bone marrow progenitor cells [25, 41, 43] and not on monocytic precursors. By using a combination of IL-4 (100 U/ml), GM-CSF (800 U/ml) and Flt3L (40 ng/ml), we were able to produce, after 7 days of culture, between 1.14´10 6 and 1.4´10 6 CD1a + cells from the adherent fraction of 10´10
6 PBMC (present in 8±10 ml peripheral blood of healthy individuals and patients with cervical SIL). The generation of DC from monocytic precursors was maximal in the presence of 100 U/ml IL-4. Previous studies used higher concentrations of IL-4 (500±1000 U/ml IL-4) and no Flt3L [33, 37, 39] Fig. 4 Individual percentage CD1a + cell increases in the presence of Flt3L (40 ng/ml) compared with number of CD1a + cells generated in medium with GM-CSF + IL-4 alone. Results are shown for patients with SIL and healthy donors blood) that is lower than that obtained in this study. We found that higher IL-4 concentrations than 100 U/ml were associated with a decrease in the number of total mononuclear cells and consequently in the number of CDla + cells. Moreover, low concentrations of IL-4 are closer to the equilibrium constant of that cytokine in vivo (50±200 U/ml). These low concentrations of IL-4 also induce not only a dierentiation of monocytes to DC but 36% of these DC show the presence of intracytoplasmic granules that are reminiscent of Langerhans cell Birbeck granules (Dr. Grassi, personal communication). Therefore, the use of 100 U/ml IL-4 may generate cells morphologically closer to Langerhans cells, the density of which has been shown to be low in HPV-transformed (pre)neoplastic cervical epithelium. The combination of Flt3L + GM-CSF + IL-4 was associated with a mean increase of 26% in DC production, compared with a culture without Flt3L. The precise mechanism of action by which Flt3L, in association with GM-CSF and IL-4, stimulates the production of DC remains unclear and requires further studies. One possibility is that Flt3L acts on CD34 + cells present in the adherent fraction of PBMC. Indeed, recent studies indicate that Flt3 receptor is expressed on puri®ed CD34 + cells [44] and absent on CD34
A cells [11] . Moreover, a variable number of CD34 + cells in each donor might explain the variable increase in CD1a + cells with Flt3L. However, it is very dicult to determine whether the percentage of CD34 + cells in the starting population accounts for the interdonor variation because the frequency of these progenitors is too low to be detected with accuracy by FACS analysis. Another possibility is that Flt3L synergizes with GM-CSF to stimulate the proliferation and dierentiation of monocytic cells [42] . Since the combination GM-CSF + IL-4 acts on the monocytic precursor population to induce DC dierentiation [37] , Flt3L might increase the yield of DC by stimulating the proliferation of monocytes and so boosting the level of precursor cells (CD14 + ).
We did not detect any signi®cant dierence in the phenotypical pro®le of DC generated with or without Flt3L. The generated cells were positive for the classical DC markers (CD1a, CD4, class II MHC, CD80, CD86, CD54, CD40). These molecules were highly expressed without major changes in antigen density. Further functional analysis revealed that the ability to stimulate allogeneic responder cells (PBMC) was retained in GM-CSF + IL-4 + Flt3L cultures. We also compared the phenotype and the functionality of DC generated from the peripheral blood of healthy donors and from patients with SIL. There was no signi®cant dierence in the phenotype and functional activity of DC between control individuals and patients with SIL. The increased DC yield induced by Flt3L was also observed in both populations. The systemic alterations of the immune system observed in patients with SIL [18] do not seem, therefore, to in¯uence the presence of DC precursors in the blood, and the decrease of Langerhans cells observed in SIL is probably related to local mechanisms (such as lack of maturation in situ or lack of chemotactic factors produced by HPV-infected keratinocytes) rather than a systemic mechanism aecting DC precursors.
In summary, we have described a simple method allowing the generation of a large number of functional DC from a relatively small amount of blood in both healthy donors and patients with SIL. The results of this study suggest that Flt3L is a promising growth factor for the in vitro generation of large number of DC, which might help to improve our understanding of the cervical carcinogenesis and be used in clinical immunotherapeutic anti cancer protocols. 
